Biopico Systems Inc.
Irvine, CA Doing business as Biopico Systems Biopico Systems Inc.
- UEI
- MU14LUW1RH41
- CAGE
- 4T0R3
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
-
- 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing Primary
- 325199 All Other Basic Organic Chemical Manufacturing
- 326199 All Other Plastics Product Manufacturing
- 333914 Measuring, Dispensing, and Other Pumping Equipment Manufacturing
- 334111 Electronic Computer Manufacturing
- 334513 Instruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables
- 334514 Totalizing Fluid Meter and Counting Device Manufacturing
- 334515 Instrument Manufacturing for Measuring and Testing Electricity and Electrical Signals
Show all
- 334516 Analytical Laboratory Instrument Manufacturing
- 334519 Other Measuring and Controlling Device Manufacturing
- 339112 Surgical and Medical Instrument Manufacturing
- 339113 Surgical Appliance and Supplies Manufacturing
- 339991 Gasket, Packing, and Sealing Device Manufacturing
- 541512 Computer Systems Design Services
- SAM.gov registration date
- Physical address
- 188 Technology Dr Ste G, Irvine, CA 92618, USA
- Website
- biopico.com
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| This project will develop the prism cmevaluate human multiorgan micro-physiological platform to assess radiation-induced… | Shared Services Center | $249,998 | |
| FY24 sbir phase i- platform for radiation-induced senescence using multiorgans (prism) for high throughput senolytics… | Shared Services Center | $166,499 | |
| A humanized organ plate paradigm for high throughput alzheimer's disease therapeutics - a humanized organ plate paradigm… | National Institute on Aging | $1,378,248 | |
| Cgmp compliant closed cell culture system for reproducible DE-differentiation of human somatic cells into ipscs | National Institute of General Medical Sciences | $2,719,228 | |
| Fluidic programmable gravi-maze array (fpga) for multi-organs drug testing | National Institute of Environmental Health Sciences | $501,518 |
About Biopico Systems Inc.
Biopico Systems Inc., located in Irvine, California, is a minority-owned, for-profit corporate entity specializing in advanced biomedical research and development of innovative organ-on-chip technologies. Registered in SAM.gov since 2007, the company focuses on developing sophisticated in vitro models and platforms for pharmaceutical research, drug discovery, and medical screening applications. The company appears to concentrate on creating high-throughput, multiorgans systems that can simulate complex biological interactions for research purposes, with a particular emphasis on developing advanced screening technologies for neurological and cellular research.
Regarding federal contract awards, Biopico Systems Inc. has been awarded a $166,499 firm fixed-price Small Business Innovation Research (SBIR) Phase I contract from NASA. This specific contract is for developing a "Platform for Radiation-Induced Senescence using Multiorgans (PRISM) for High Throughput Senolytics Screening," which supports NASA's research initiatives. The contract was set aside for small businesses and has a performance period through February 6, 2025. The contract type is a purchase order, indicating a focused, specific research development project within NASA's innovation ecosystem.
In terms of federal grant awards, Biopico Systems Inc. has received multiple significant grants from different National Institutes of Health (NIH) divisions. These grants include a grant from the National Institute on Aging (R43AG073040) for developing a "Humanized Organ Plate Paradigm for High Throughput Alzheimer's Disease Therapeutics," a grant from the National Institute of General Medical Sciences (R44GM139413) for creating a cGMP compliant closed cell culture system for de-differentiating human somatic cells into iPSCs, and a grant from the National Institute of Environmental Health Sciences (R43ES032357) for developing a Fluidic Programmable Gravi-Maze Array for multi-organ drug testing. These grants demonstrate the company's expertise in developing advanced cellular research platforms, with a strong focus on neurological disease research, cellular transformation techniques, and innovative drug screening methodologies.
SBA capabilities narrative
R&D in microfluidics, electrical sensing, cell based assays, electronics instrumentation
Quick answers
What is Biopico Systems Inc.'s UEI?
Biopico Systems Inc.'s Unique Entity ID (UEI) in SAM.gov is MU14LUW1RH41.
What is Biopico Systems Inc.'s CAGE code?
Biopico Systems Inc.'s CAGE code is 4T0R3.
What is Biopico Systems Inc.'s primary NAICS code?
Biopico Systems Inc.'s primary NAICS code is 334510 (Electromedical and Electrotherapeutic Apparatus Manufacturing).
Where is Biopico Systems Inc. located?
Biopico Systems Inc.'s physical address in SAM.gov is 188 Technology Dr Ste G, Irvine, CA 92618, USA.
Is Biopico Systems Inc. registered in SAM.gov?
Yes. Biopico Systems Inc.'s SAM.gov registration is active through August 3, 2027.
What is Biopico Systems Inc.'s most recent federal award?
Biopico Systems Inc.'s most recent federal contract award is This project will develop the prism cmevaluate human multiorgan micro-physiological platform to assess radiation-induced… (80NSSC26P0952), from Shared Services Center, on July 7, 2026.
On GovTribe
See Biopico Systems Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors